Apr 18, 2023 / 06:15PM GMT
Serge Belanger - Needham & Company, LLC - Analyst
Hi, good afternoon. I'm Serge Belanger. I'm one of the senior healthcare analysts at Needham. I want to welcome you to Needham's 22nd Annual Healthcare Conference. And for our next session, we have the Collegium Pharmaceuticals team. We have the CEO and President, Joe Ciaffoni; as well as the CFO, Colleen Tupper.
So I'll hand it over to Joe to get us started. He'll give us a quick overview of the company and then we'll go to questions. (Conference Instructions) So Joe, please.
Joe Ciaffoni - Collegium Pharmaceutical, Inc. - President & CEO
Great. And Serge, thank you as always, for the opportunity to participate in the conference. Colleen and I appreciate that opportunity very much. 2023 for Collegium is a year we're excited about. We believe 2023 will be a banner year, and that's what we're setting out to achieve. We're proud of our leading commercial portfolio.
We have a strong financial position, and we're committed to taking a disciplined approach to capital deployment with the
Collegium Pharmaceutical Inc at Needham Healthcare Conference (Virtual) Transcript
Apr 18, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers